Page last updated: 2024-09-02

ci 988 and Briquet Syndrome

ci 988 has been researched along with Briquet Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adams, JB; Costa, J; Cutler, NR; Greiner, M; Pande, AC; Pierce, MW; Pyke, RE; Schweizer, E; Wilcox, CS; Wisselink, PG	1

Trials

1 trial(s) available for ci 988 and Briquet Syndrome

Article	Year
A double-blind, placebo-controlled study of a CCK-B receptor antagonist, CI-988, in patients with generalized anxiety disorder. Journal of clinical psychopharmacology, 1995, Volume: 15, Issue:6 Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Colonic Diseases, Functional; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Indoles; Male; Meglumine; Panic Disorder; Personality Inventory; Phobic Disorders; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Somatoform Disorders; Treatment Outcome	1995

Article

Year

A double-blind, placebo-controlled study of a CCK-B receptor antagonist, CI-988, in patients with generalized anxiety disorder.

Journal of clinical psychopharmacology, 1995, Volume: 15, Issue:6

Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Colonic Diseases, Functional; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Indoles; Male; Meglumine; Panic Disorder; Personality Inventory; Phobic Disorders; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Somatoform Disorders; Treatment Outcome

1995